We have located links that may give you full text access.
Midterm Results of Prospective Study for Aortic dissection with Gutter-Plugging Chimney Stent-Graft.
European Journal of Cardio-thoracic Surgery 2024 April 4
BACKGROUND: To access early and midterm outcomes of a gutter-plugging chimney stent-graft for treatment of Stanford type B aortic dissections (TBAD) in the clinical trial of Prospective Study for Aortic Arch Therapy with stENt-graft for Chimney technology (PATENCY).
METHODS: Between October 2018 and March 2022, patients with TBAD were treated with the LonguetteTM chimney stent-graft in 26 vascular centers. The efficiency and the incidence of adverse event over 12 months were investigated.
RESULTS: :A total of 150 patients were included. The technical success rate was 99.33% (149/150). The incidence of immediate postoperative endoleak was 5.33% (8/150, type I, n = 6; type II, n = 1; type IV, n = 1), neurologic complications (stroke or spinal cord ischemia) and 30-day mortality were 0.67% (1/150) and 1.33% (2/150), respectively. During the follow-up, the median follow-up time was 11.67 (5-16) months. The patent rate of Longuette graft is 97.87%. Two type I endoleak patients underwent reintervention. The follow-up rate of incidence of retrograde A type aortic dissection was 0.67% (1/150). There was no paraplegia, left arm ischemia, or stent migration.
CONCLUSION: For revascularization of the left subclavian artery, the LonguetteTM chimney stent graft can provide an easily manipulated, safe, and effective endovascular treatment. It should be considered a more efficient technique to prevent type Ia endoleak. Longer follow-up and a larger cohort are needed to validate these results.
METHODS: Between October 2018 and March 2022, patients with TBAD were treated with the LonguetteTM chimney stent-graft in 26 vascular centers. The efficiency and the incidence of adverse event over 12 months were investigated.
RESULTS: :A total of 150 patients were included. The technical success rate was 99.33% (149/150). The incidence of immediate postoperative endoleak was 5.33% (8/150, type I, n = 6; type II, n = 1; type IV, n = 1), neurologic complications (stroke or spinal cord ischemia) and 30-day mortality were 0.67% (1/150) and 1.33% (2/150), respectively. During the follow-up, the median follow-up time was 11.67 (5-16) months. The patent rate of Longuette graft is 97.87%. Two type I endoleak patients underwent reintervention. The follow-up rate of incidence of retrograde A type aortic dissection was 0.67% (1/150). There was no paraplegia, left arm ischemia, or stent migration.
CONCLUSION: For revascularization of the left subclavian artery, the LonguetteTM chimney stent graft can provide an easily manipulated, safe, and effective endovascular treatment. It should be considered a more efficient technique to prevent type Ia endoleak. Longer follow-up and a larger cohort are needed to validate these results.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app